Oric Pharmaceuticals: EcoR1 reports 2.9% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Oric Pharmaceuticals, Inc. (ORIC) common stock is the subject of an amended ownership report by EcoR1 Capital, LLC, Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. EcoR1 and Nodelman each reported beneficial ownership of 3,028,116 shares (2.9%); Qualified Fund reported 2,885,435 shares (2.8%). Each reported shared voting and dispositive power over its stated amount and zero sole voting or dispositive power. EcoR1 is the general partner and investment adviser of funds including Qualified Fund, and Nodelman is EcoR1’s control person. The reporting persons stated they filed jointly, not as a group, and disclaimed beneficial ownership except to the extent of each person’s pecuniary interest.
Key Figures
Beneficial ownership — EcoR1 Capital, LLC: 3,028,116 shares
Beneficial ownership — Oleg Nodelman: 3,028,116 shares
Beneficial ownership — EcoR1 Capital Fund Qualified, L.P.: 2,885,435 shares
+4 more
7 metrics
Beneficial ownership — EcoR1 Capital, LLC
3,028,116 shares
Reported as 2.9% of the class.
Beneficial ownership — Oleg Nodelman
3,028,116 shares
Reported as 2.9% of the class.
Beneficial ownership — EcoR1 Capital Fund Qualified, L.P.
2,885,435 shares
Reported as 2.8% of the class.
Ownership percentage — EcoR1 Capital, LLC
2.9%
Percentage of the class reported.
Ownership percentage — Oleg Nodelman
2.9%
Percentage of the class reported.
Ownership percentage — EcoR1 Capital Fund Qualified, L.P.
2.8%
Percentage of the class reported.
Common shares outstanding
103,652,656 shares
Outstanding as of July 27, 2026; denominator used for the reported percentages.
Key Terms
beneficial ownership, shared voting power, shared dispositive power, pecuniary interest, +1 more
5 terms
beneficial ownership regulatory
"Each reporting person also disclaims beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest regulatory
"except to the extent of that person's pecuniary interest therein"
Rule 13d-3 regulatory
"beneficial owner, as defined in Rule 13d-3 under the Act"
Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What denominator was used for the ORIC ownership percentages?
The percentages were calculated using 103,652,656 ORIC common shares outstanding as of July 27, 2026.
How are EcoR1 Capital and Oleg Nodelman connected to Qualified Fund?
EcoR1 Capital, LLC is the general partner and investment adviser of investment funds including Qualified Fund. Oleg Nodelman is EcoR1 Capital’s control person.
AI-generated analysis. How Rhea-AI works. Not financial advice.